戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              ER alpha activation of mGluR1a is dependent on CAV1, whe
2                                              ER alpha and ER beta agonists PPT and DPN inhibited and
3                                              ER alpha binds to a potential Stat5a ERE.
4                                              ER alpha mRNA was expressed more abundantly on EPCs comp
5                                              ER alpha plays a more prominent role in this process.
6                                              ER alpha signals through multiple pathways, which can be
7                                              ER alpha t(1/2) was reduced in ER alpha-negative cell li
8                                              ER alpha-negative primary breast cancers and cell lines
9                                              ER-alpha did not repress transcription of an HBV replico
10                                              ER-alpha expression may be regulated in melanoma via hyp
11                                              ER-alpha methylation status in tumor (n = 107) and sera
12                                              ER-alpha was methylated more frequently in metastatic th
13 ion of pERK1/2 MAPK, phosphorylated Ser(118)-ER-alpha, and cyclin D1.
14 lar cross-talks and side-talks among IGF-1R, ER-alpha, and phosphatidylinositol 3-kinase (PI3K)/Akt s
15 able and overlapping ESR1 mRNA levels in 200 ER alpha-negative and 50 ER alpha-positive primary breas
16  mRNA levels in 200 ER alpha-negative and 50 ER alpha-positive primary breast cancers examined, which
17 premalignant (EIII8) or tumorigenic (MCF-7), ER-alpha(+) tamoxifen-resistant (EIII8-TAM(R)) or ER-alp
18 s suggest that 3MC and PCB directly activate ER alpha, and this was confirmed in a competitive ER alp
19 ults show that PCB and 3MC directly activate ER alpha-dependent transactivation and extend the number
20 hat Src cooperates with estrogen to activate ER alpha proteolysis.
21 y proliferation, but also estrogen-activated ER alpha loss in a subset of ER alpha-negative breast ca
22          Src siRNA impaired ligand-activated ER alpha loss in BT-20 cells.
23    Inducible Src stimulated ligand-activated ER alpha transcriptional activity and reduced ER alpha t
24     Src inhibition impaired ligand-activated ER alpha ubiquitylation and increased ER alpha levels.
25          Thus, in weanling rats sex affected ER alpha and ER beta neuronal densities in brainstem reg
26    Nuclear receptor estrogen receptor alpha (ER alpha) controls the expression of hundreds of genes r
27 sion correlate with estrogen receptor alpha (ER alpha) expression in breast tumors.
28 ranslocation of the estrogen receptor alpha (ER alpha) have been described, but the mechanisms releva
29 hly correlated with estrogen receptor alpha (ER alpha) in human breast tumors.
30 hly correlated with estrogen receptor alpha (ER alpha) in human breast tumors.
31 ctivity through AhR-estrogen receptor alpha (ER alpha) interactions.
32                     Estrogen receptor alpha (ER alpha) mediates breast cancer proliferation through t
33 ally interacts with estrogen receptor alpha (ER alpha), both in vitro and in vivo.
34 interaction between estrogen receptor alpha (ER alpha), caveolin-1 (Cav-1) and c-Src, and increased p
35 3-H1 in influencing estrogen receptor alpha (ER alpha)-mediated gene expression.
36  and proteolysis of estrogen receptor alpha (ER alpha; encoded by ESR1).
37 activator protein-1/estrogen receptor-alpha (ER alpha) complex to the proximal BRCA-1 promoter.
38 membrane-associated estrogen receptor-alpha (ER alpha) led to activation of metabotropic glutamate re
39 ulation by siRNA of estrogen receptor-alpha (ER alpha), but not ER beta, inhibited estrogen-stimulate
40 ever, the roles of estrogen receptors alpha (ER alpha) and beta (ER beta) in EPC biology are largely
41 n receptor (AR) and estrogen receptor alpha (ER-alpha) activity is higher in digit 4 than in digit 2.
42  cotransfected with estrogen receptor alpha (ER-alpha) after 17beta-estradiol stimulation.
43  aromatase, bind to estrogen receptor alpha (ER-alpha) and estrogen receptor beta (ER-beta), and anta
44 tradiol (E2)-bound oestrogen receptor alpha (ER-alpha) causes a global increase in eRNA transcription
45         The role of estrogen receptor alpha (ER-alpha) in melanoma is unknown.
46                     Estrogen receptor alpha (ER-alpha) is a nuclear hormone receptor that controls se
47 E2 treatment of the estrogen receptor alpha (ER-alpha) negative MCF-10F cell line on the in vitro exp
48  breast cancers are estrogen receptor alpha (ER-alpha) positive, and although women typically initial
49                 The estrogen receptor alpha (ER-alpha) regulates expression of target genes implicate
50 re mediated via the estrogen receptor alpha (ER-alpha), the existence of another novel ER, G protein-
51 uced recruitment to estrogen receptor alpha (ER-alpha)-bound eRNA(+) active enhancers in interphase b
52  variable levels of estrogen receptor-alpha (ER-alpha) and androgen receptors.
53                     Estrogen receptor-alpha (ER-alpha) and ER-beta exhibit fine differences in their
54 eatly overexpressed estrogen receptor-alpha (ER-alpha) and pS2, an estrogen-regulated gene.
55  in the function of estrogen receptor-alpha (ER-alpha) as assessed by serine 305 (S305) activation an
56 In rat hippocampus, estrogen receptor-alpha (ER-alpha) can initiate nongenomic signaling mechanisms t
57 ting in the loss of Estrogen Receptor-alpha (ER-alpha) expression and other luminal markers.
58  involvement of the estrogen receptor-alpha (ER-alpha) in locomotor recovery, is still a subject of m
59  through decreasing estrogen receptor-alpha (ER-alpha) level when cultured with luminal BrCA cell lin
60                     Estrogen receptor-alpha (ER-alpha) plays a crucial role in normal breast developm
61 nd to interact with estrogen receptor-alpha (ER-alpha), and HE4 overexpression resulted in ER-alpha d
62 ck of expression of estrogen receptor-alpha (ER-alpha), progesterone receptor (PR), and human epiderm
63 xifen resistance in estrogen receptor-alpha (ER-alpha)-positive breast cancers.
64  markers, including estrogen receptor-alpha (ER-alpha, encoded by ESR1).
65 ds of cases express estrogen receptor-alpha (ER-alpha, encoded by ESR1).
66 recruited to the ERE of BRCA1 promoter in an ER alpha-dependent manner.
67  (<2 nm) to lower affinity complexes with an ER alpha monomer at higher SRC-RID concentrations (appro
68    A Notch mimetic peptide could activate an ER-alpha promoter reporter in a BRCA1-dependent manner,
69 nsylcadaverine, and proteolysis of BSA in an ER-alpha dependent manner, and increased resistance to 4
70 ion in the developing hippocampus through an ER-alpha-dependent mechanism.
71 ause functional recovery was blocked with an ER-alpha antagonist.
72 ts for the robust coexpression of GATA-3 and ER alpha in human breast cancers.
73                         Moreover, GATA-3 and ER alpha regulate their own expression in breast cancer
74 o be a novel link between Src activation and ER alpha proteolysis and support a model whereby crossta
75 number of ligands that activate both AhR and ER alpha.
76                                      Src and ER alpha levels were inversely correlated in primary bre
77 educed sensitivity to U0126 or LY294002, and ER-alpha hyperphosphorylation in the activation function
78            Characteristically, NSP cells are ER-alpha positive and epithelial type with little tumori
79 rs of reduced risk of NSCLC characterized as ER-alpha and/or ER-beta positive.
80 ins in cerebrovascular mitochondria, such as ER-alpha, cytochrome c, subunit IV of complex IV, and ma
81                                  We assessed ER-alpha hypermethylation in primary and metastatic mela
82 itation assays showed an interaction between ER-alpha and HNF-4alpha; this interaction prevented HNF-
83                                         Both ER alpha and ER beta contribute to E2-mediated EPC activ
84                                      In both ER alpha-positive and -negative cell lines, both proteas
85      Estradiol increased the density of both ER-alpha and ER-beta protein clusters along dendrites.
86   Based on these findings, a partial BRCA1 : ER-alpha three-dimensional structure is proposed.
87 ucture/function relationship for the BRCA1 : ER-alpha interaction.
88  involves selective trimming of N-glycans by ER alpha-mannosidase I and subsequent recognition by the
89 gen to enhance transcriptional activation by ER-alpha of endogenous estrogen-responsive genes.
90                Gene expression controlled by ER-alpha is modulated by Ca(2+) via calmodulin (CaM).
91 cific enhancer-promoter looping initiated by ER-alpha binding.
92 he lesion cavity, an effect also mediated by ER-alpha.
93                  A model of the complete CaM.ER-alpha complex was constructed by combining these two
94  experiment in which PCB and 3MC induced CFP-ER alpha/YFP-ER alpha interactions.
95 pha, and this was confirmed in a competitive ER alpha binding assay and in a fluorescence resonance e
96 I8-Tam(R) cells correlated with constitutive ER-alpha hyperphosphorylation that was unaffected by the
97 owever, the mean size of synapses containing ER-alpha was larger than that of unlabeled excitatory sy
98 percentage of excitatory synapses containing ER-alpha, nor were there any group differences in distri
99 e differentially associated with cytoplasmic ER-alpha and/or nuclear ER-beta expression-defined NSCLC
100 er (SERD) that both antagonizes and degrades ER-alpha and is active in patients who have progressed o
101            Tumors were poorly differentiated ER-alpha and progesterone receptor-negative adenocarcino
102  regulation involving AP1 motifs that direct ER alpha-DNA interaction is required to increase Igf1 tr
103                               Thus, distinct ER alpha signaling pathways can differentially regulate
104 act within the same neuron through divergent ER alpha signaling pathways to regulate different neurot
105 alk between liganded ER alpha and Src drives ER alpha transcriptional activity and targets ER alpha f
106 tivation, at least in part by stabilizing E2/ER-alpha/eRNA-induced enhancer-promoter looping.
107                      Depletion of endogenous ER alpha, not ERbeta, by siRNA attenuated resveratrol- a
108 unoprecipitation assay, PCB and 3MC enhanced ER alpha (but not AhR) association with the estrogen-res
109  crystal structures of the main ERQC enzyme, ER alpha-glucosidase II (alpha-GluII; from mouse), alone
110              Upon the addition of estradiol, ER alpha binds directly to this distal enhancer in vivo,
111 munolabeling for androgen (AR) and estrogen (ER alpha) receptors revealed no colocalization of hcrt/o
112  to triple-negative ones that do not express ER-alpha- and Her-2 and are highly tumorigenic in xenogr
113  with AR and few hcrt/orx neurons expressing ER alpha, suggesting that hormonal regulation of hcrt/or
114 postnatal days (PNDs) 0, 2, 4, 7, and 19 for ER alpha (ERalpha; Esr1), beta (ERbeta; Esr2), and Kiss1
115                     Counts and densities for ER alpha were greater in females than males in almost al
116 ndent on CAV1, whereas CAV3 is necessary for ER alpha and ER beta activation of mGluR2/3.
117 e transfection of a small inhibitory RNA for ER alpha but were not affected by the small inhibitory R
118 e deacetylase activity were not required for ER-alpha-mediated repression of HBV genes.
119 were severely impaired in EPCs obtained from ER alpha-knockout mice (ER alphaKO) and moderately impai
120 enesis when cocultured with fibroblasts from ER-alpha(-)/PgR(-) or ER-alpha(+)/PgR(+) breast tumors;
121                  Given this progression from ER-alpha-positive to ER-alpha-negative lesions, we teste
122                           Additionally, full ER alpha function is needed to mediate other cellular si
123  on the expression of tumor suppressor genes ER-alpha and CDH1 in MDA-MB-231 breast cancer cells.
124            The molecular mechanism governing ER-alpha transcriptional activity and/or silencing is st
125 ent aromatase inhibitory activities and high ER-alpha and ER-beta binding affinities of several of th
126                                     However, ER-alpha gene expression can change during the course of
127                              Hypermethylated ER-alpha is a significant factor in melanoma progression
128    However, the functional role of GATA-3 in ER alpha-positive breast cancers is yet to be establishe
129 4'-nitroflavone; (b) transient expression in ER alpha-negative HeLa cells of ER alpha lacking the pro
130                          miR-21 is higher in ER alpha positive than negative tumors, but no one has e
131               ER alpha t(1/2) was reduced in ER alpha-negative cell lines.
132 e was a HIF-1alpha-dependent CSC increase in ER-alpha-positive cancers following hypoxic exposure, wh
133 orm salt bridges with key lysine residues in ER-alpha (Lys(299), Lys(302), and Lys(303)), which are l
134 orm salt bridges with key lysine residues in ER-alpha (Lys-299, Lys-302, and Lys-303), which is likel
135 R-alpha), and HE4 overexpression resulted in ER-alpha downregulation in vitro and in human ovarian ca
136    A contrasting decrease in CSC was seen in ER-alpha-negative cancers.
137 ith poor response to antihormonal therapy in ER-alpha-positive breast cancer.
138 e-specific transcriptional network including ER alpha and FoxA1 that dictates the phenotype of hormon
139 f hormone-dependent breast cancer, including ER-alpha, FOXA1 and GATA-3.
140 ivated ER alpha ubiquitylation and increased ER alpha levels.
141 both proteasome and Src inhibitors increased ER alpha levels.
142              Pretreatment with Src increased ER alpha ubiquitylation and degradation in vitro.
143 n neonatal uteri, prenatal arsenic increased ER-alpha expression and enhanced estrogen-related gene e
144  not in KIKO or alpha ERKO uteri, indicating ER alpha- and ERE-dependent regulation.
145 monstrate that nanomolar resveratrol induces ER alpha-Cav-1-c-SRC interaction, resulting in NO produc
146  ER alpha indicating that the suppression is ER alpha-mediated.
147 cts via the estrogen receptor alpha isoform (ER alpha) to regulate Kiss1 expression.
148 f the human estrogen receptor alpha-isoform (ER alpha) with the receptor interacting domains (RIDs) o
149 t a model whereby crosstalk between liganded ER alpha and Src drives ER alpha transcriptional activit
150  between the unliganded AhR and the liganded ER alpha plays a positive role in E2-dependent activatio
151                     Cohesin, present on many ER-alpha-regulated enhancers even before ligand treatmen
152   We confirmed a role for Runx1 in mediating ER alpha genomic recruitment and regulation of tethering
153 cells was suppressed as a result of membrane ER-alpha signaling through several kinases to inhibit ca
154 nly ER-alpha (NOER) mice] or plasma membrane ER-alpha [membrane-only ER-alpha (MOER) mice], we found
155                                   Methylated ER-alpha was detected in 42% (8 of 19) of stage III and
156 in AJCC stage I, II, III, and IV, methylated ER-alpha was detected in 10% (2 of 20), 15% (3 of 20), 2
157                             Serum methylated ER-alpha is an unfavorable prognostic factor.
158 he clinical significance of serum methylated ER-alpha was assessed among AJCC stage IV melanoma patie
159                             Serum methylated ER-alpha was detected more frequently in advanced than l
160                                    Moreover, ER alpha contributes to upregulation of vascular endothe
161 d binding domains (E domains) of human/mouse ER alpha and ER beta, progesterone receptors A and B, an
162 script in a mouse with a DNA-binding mutated ER alpha (KIKO), indicating that both Igf1 regulation an
163   We found that suppression of GPR30 but not ER-alpha prevented E2-BSA- or E2-induced PKA activation
164  the PKA-dependent pathway via GPR30 but not ER-alpha.
165   We concluded that extranuclear and nuclear ER-alpha collaborate to suppress adipocyte development,
166 sis in mature cells does not involve nuclear ER-alpha.
167         Using mice that express only nuclear ER-alpha [nuclear-only ER-alpha (NOER) mice] or plasma m
168 lated variables were associated with nuclear ER-alpha- or ER-beta-negative NSCLC.
169       Nuclear Smad co-localized with nuclear ER-alpha.
170               The complementary abilities of ER alpha and NM23-H1 together to influence gene expressi
171 of carcinogenesis will require antagonism of ER alpha but not ER beta.
172 xpression in ER alpha-negative HeLa cells of ER alpha lacking the protein-binding domain for the AhR;
173 le rats to quantitate areas and densities of ER alpha and ER beta-positive neurons within medullary r
174 timulated breast cancer growth downstream of ER alpha and AIB1 and upstream of the cell cycle regulat
175 emonstrating the physiological importance of ER alpha-to-mGluR1a signaling.
176                          The interactions of ER alpha with all three SRC-RIDs, measured throughout th
177                           siRNA knockdown of ER alpha blocked the E(2)-induced increase in Pdcd4, PTE
178  a process that parallels the recruitment of ER alpha.
179 transferase CARM1 is a positive regulator of ER alpha-mediated transcriptional activation.
180 e crucial role of GATA-3 for the response of ER alpha-positive breast cancers to estradiol.
181 ods also showed that only a subpopulation of ER alpha was available to form complexes with the SRC-RI
182 rogen-activated ER alpha loss in a subset of ER alpha-negative breast cancers, altering prognosis and
183 oss age and treatment, synaptic abundance of ER-alpha is correlated with individual performance in tw
184 ion of MEK5 included increased activation of ER-alpha independent growth signaling pathways and promo
185                                Activation of ER-alpha is one mechanism by which PRL may contribute to
186 downregulation of expression and activity of ER-alpha and the progesterone receptor (PR), MEL-18 over
187                        Direct DNA binding of ER-alpha and histone deacetylase activity were not requi
188 methylation led to an increase in binding of ER-alpha to the Hoxa10 ERE both in vitro as and in vivo
189  ChIP assay demonstrated that the binding of ER-alpha to the SNAT2 promoter gradually increased in th
190 sistance through IL-6-induced degradation of ER-alpha in luminal BrCAs.Oncogene advance online public
191 on at these sites and inhibit degradation of ER-alpha.
192 on at these sites and inhibit degradation of ER-alpha.
193 hich are potent antagonists and degraders of ER-alpha and in which the ER-alpha degrading properties
194              CaM facilitates dimerization of ER-alpha in the absence of estrogen, and stimulation of
195 ata suggest that CaM-induced dimerization of ER-alpha is required for estrogen-stimulated transcripti
196 ere any group differences in distribution of ER-alpha within the synapse.
197                         The distributions of ER-alpha immunoreactivity (ir) and ER-beta ir were nonov
198 is region, overcame the repressive effect of ER-alpha.
199  higher 2D:4D ratio, whereas inactivation of ER-alpha increases growth of digit 4, which leads to a l
200  that selectively disrupt the interaction of ER-alpha with CaM may be useful in the therapy of breast
201 his binding competes with the interaction of ER-alpha with its consensus ERE.
202 rin (Lf) efficiently downregulates levels of ER-alpha, PR, and HER-2 in a proteasome-dependent manner
203 ture of Ca(2+)-CaM bound to two molecules of ER-alpha (residues 287-305).
204 hich explains why CaM binds two molecules of ER-alpha in a 1:2 complex and stabilizes ER-alpha dimeri
205 s why full-length CaM binds two molecules of ER-alpha in a 1:2 complex and stabilizes ER-alpha dimeri
206                                   Mutants of ER-alpha at the CaM-binding site (W292A and K299A) weake
207 aintaining a specific methylation pattern of ER-alpha gene.
208 for understanding how the complex pattern of ER-alpha methylation and transcriptional silencing is ge
209  cells with PRL increased phosphorylation of ER-alpha at residues implicated in unliganded ER-alpha a
210                                     Rates of ER-alpha methylation in AJCC stage I, II, and III primar
211 s of CaM each bound to a localized region of ER-alpha (residues 287-305).
212 ermeable) or E2 induced the up-regulation of ER-alpha and GPR30 and attenuated hepatic injury.
213              Calcium-dependent regulation of ER-alpha is critical for activating gene expression and
214             In HepG2 cells, up-regulation of ER-alpha reduced HBV transcription, which required a spe
215 thway- specific, and the local remodeling of ER-alpha chromatin structure by pRb2/p130 multimolecular
216 gative cells rescues the BRCA1 repression of ER-alpha activity and that the E7 and E6 oncoproteins in
217 xposures are associated with reduced risk of ER-alpha- and ER-beta-expressing NSCLC.
218             In light of the critical role of ER-alpha in breast carcinoma, our data suggest that smal
219 ses to estradiol and IGF1 via scaffolding of ER-alpha/PELP1/IGF1R-containing complexes.
220 ishing and maintaining the silenced state of ER-alpha gene can be locus- or pathway- specific, and th
221  the absence of estrogen, and stimulation of ER-alpha by either Ca(2+) and/or estrogen may serve to r
222 eviously, our laboratory cloned a variant of ER-alpha, ER-alpha36, and found that ER-alpha36 mediated
223 or (ER)-alpha36, a membrane-based variant of ER-alpha.
224 both compete for binding at the same site on ER-alpha (residues 292, 296, 299, 302, and 303), which e
225 ] or plasma membrane ER-alpha [membrane-only ER-alpha (MOER) mice], we found that 10-wk-old mice that
226  express only nuclear ER-alpha [nuclear-only ER-alpha (NOER) mice] or plasma membrane ER-alpha [membr
227 ovariectomized wild-type mice received E2 or ER-alpha agonist propyl pyrazole triol (50 microg/25 g)
228 trauma-hemorrhage are mediated via GPR30- or ER-alpha-regulated activation of PKA-dependent signaling
229  with fibroblasts from ER-alpha(-)/PgR(-) or ER-alpha(+)/PgR(+) breast tumors; however, EIII8 cells c
230 pha(+) tamoxifen-resistant (EIII8-TAM(R)) or ER-alpha(-) MDA-MB-231 breast cancer cells to interact a
231 Ds demonstrated selectivity for ER-beta over ER-alpha.
232 reduction of P-MAPK, P-Akt, P-S6, and S118 P-ER alpha in hormone receptor-positive cancers.
233 FR, P-HER-2, P-MAPK, P-Akt, P-S6, and S118 P-ER alpha.
234 ed with the ability of PAK1 to phosphorylate ER-alpha on serine 305 and subsequent secondary activati
235 which suggests important posttranscriptional ER alpha regulation.
236 zed monkeys without E treatment, presynaptic ER-alpha correlated with DR accuracy across memory delay
237 PR30 versus the classical estrogen receptors ER alpha/beta and functional responses associated with l
238                                Reciprocally, ER alpha directly stimulates the transcription of the GA
239 R alpha transcriptional activity and reduced ER alpha t(1/2).
240  transcription of HBV genes by up-regulating ER-alpha, which interacts with and alters binding of HNF
241 n sharp contrast, the more distantly related ER-alpha dimerizes so strongly that energetics can only
242              Overexpression of MKP3 rendered ER-alpha-positive breast cancer cells resistant to the g
243 eceptor (PR), MEL-18 overexpression restored ER-alpha expression in TNBC.
244 omatin immunoprecipitation analysis revealed ER alpha binding to these EREs in wild type but not KIKO
245 sion of CCN5 in SP results in EMT reversion, ER-alpha upregulation and delays in tumor growth in xeno
246                                     The same ER-alpha-dependent contrasting hypoxic-CSC response was
247 of CaM bind to the same site on two separate ER-alpha molecules (residues 292, 296, 299, 302, and 303
248  inhibition of estrogen induction of several ER alpha-associated genes, including TFF1, by HMGN1 corr
249 s were due to ER alpha or ER beta signaling, ER alpha-knockout (alphaERKO) or ERbeta-knockout (betaER
250 n (4-OHT), ICI 182 780 (Faslodex), and siRNA ER alpha indicating that the suppression is ER alpha-med
251 estern blot analysis revealed that the SNAT2 ER-alpha-ERE complex contained poly(ADP-ribose) polymera
252  of ER-alpha in a 1:2 complex and stabilizes ER-alpha dimerization.
253  of ER-alpha in a 1:2 complex and stabilizes ER-alpha dimerization.
254 f transcription through the two ER subtypes, ER alpha and ER beta.
255 romoting complex 10 activity, which targeted ER-alpha degradation through the ubiquitin-proteasome pa
256 R alpha transcriptional activity and targets ER alpha for ubiquitin-dependent proteolysis.
257 em regions examined were less prevalent than ER alpha neurons.
258  Stat5a transcript through ERE binding; that ER alpha, either alone or together with STAT5, then acts
259          Here we present data that show that ER alpha and mGluR1a directly interact to mediate a rapi
260 electron microscopic data demonstrating that ER-alpha is present within excitatory synapses in dorsol
261                        We also observed that ER-alpha was up-regulated after SCI.
262 lly, EMSAs and supershift assays showed that ER-alpha binds to the SNAT2 ERE and that this binding co
263                      These data suggest that ER-alpha-positive and negative breast cancer subtypes re
264 ough the lack of group effects suggests that ER-alpha is primarily in synapses that are stable across
265                                          The ER alpha and beta (ERalpha and ERbeta) were also identif
266 ions associated with the MYC pathway and the ER alpha network to be among the most differential betwe
267 HMGN1 association through recruitment by the ER alpha.
268  of mice bearing targeted alterations in the ER alpha signaling pathways.
269 H1 interacts with ER alpha and increases the ER alpha-estrogen response element (ERE) interaction.
270         On the FOS promoter, which lacks the ER alpha binding sites, constitutively bound serum respo
271 positive regulation of the expression of the ER alpha gene itself by GATA-3.
272 s (XRE, 5'-GCGTG-3') located upstream of the ER alpha-binding region.
273 o cis-regulatory elements located within the ER alpha gene, and this is required for RNA polymerase I
274 10)-tri ene-3,17-diol (ICI 182,780)] and the ER-alpha- and ER-beta-specific agonists [1,3,5-tris(4-hy
275 these protective effects are mediated by the ER-alpha dependent and independent-mechanisms.
276 o significantly delayed tumorigenesis in the ER-alpha-positive high premalignant line PN8a from 100%
277 cates that ER-alpha36 is a new member of the ER-alpha family that mediates membrane-initiated estroge
278 ific pRb2/p130 multimolecular complex on the ER-alpha promoter strongly correlates with the methylati
279 s and degraders of ER-alpha and in which the ER-alpha degrading properties were prospectively optimiz
280 activity mainly by aromatization and through ER alpha.
281 ne whether E2-mediated responses were due to ER alpha or ER beta signaling, ER alpha-knockout (alphaE
282 equired for RNA polymerase II recruitment to ER alpha promoters.
283 vator genes, CAPER and Foxa1, in addition to ER-alpha.
284 n this progression from ER-alpha-positive to ER-alpha-negative lesions, we tested the ability of tamo
285   In aged monkeys that received E treatment, ER-alpha within the postsynaptic density (30-60 nm from
286  alter latency to tumor development or tumor ER-alpha expression.
287 -containing DNA (DBDmut ER) versus wild-type ER alpha.
288 R-alpha at residues implicated in unliganded ER-alpha activity.
289 t CA12 is robustly regulated by estrogen via ER alpha in breast cancer cells, and that this regulatio
290 as its blockade of fluvoxamine's effects was ER alpha-mediated.
291                              This effect was ER-alpha mediated, because functional recovery was block
292    The majority of the resultant tumors were ER-alpha-negative.
293 sed Src levels and/or activity compared with ER alpha-positive cancers and cells.
294 hniques, we show that NM23-H1 interacts with ER alpha and increases the ER alpha-estrogen response el
295 inding nucleosomal DNA, still interacts with ER alpha and, strikingly, still represses estrogen-drive
296 sitivity compared with cells cocultured with ER-alpha(+)/PgR(+) tumor fibroblasts.
297 tumors; however, EIII8 cells cocultured with ER-alpha(-)/PgR(-) tumor-derived fibroblasts exhibited d
298 s, exhibiting non-canonical interaction with ER-alpha via its DNA-binding domain (DBD).
299 man mammary epithelial cells with or without ER-alpha transfection.
300 n which PCB and 3MC induced CFP-ER alpha/YFP-ER alpha interactions.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top